Medication info
Empagliflozin 10 mg (Dapagliflozin Propanediol Hydrate)

Empagliflozin 10 mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
Macnulty Pharmaceuticals Co., Ltd.
Appearance
Yellow, biconvex, diamond-shaped film-coated tablets
Packaging
PTP - 28 tablets/box [28 tablets (7 tablets/PTP x 4)], bottle - 30 tablets/bottle
Approval status
Active

MFDS item code 202203469 · Approved 2022.08.31 · Insurance code 641502900

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, including insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received treatment for diabetes, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dosage adjustment is necessary for patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dosage adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. Swallow the tablet whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Macnulty Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • blood sugar control disorders
  • cardiovascular disease
  • cardiovascular risk factors
View approved original text

This medicine helps control blood sugar levels in patients with type 2 diabetes. It can be used alone or in combination with other medications when combined with dietary and exercise therapy. It is particularly beneficial for type 2 diabetes patients with cardiovascular disease or risk factors that are not well controlled. Please ensure to follow the instructions of healthcare professionals and check precautions when taking this medication. This drug is used to improve blood sugar control and manage the risk of cardiovascular events.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, including insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received treatment for diabetes, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dosage adjustment is necessary for patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dosage adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. Swallow the tablet whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be used in patients with hypersensitivity to its active ingredient or excipients. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Patients with genetic lactose intolerance, lactase deficiency, or glucose-galactose malabsorption should not take this medication due to the lactose it contains. This drug should not be administered to patients undergoing dialysis. Patients who have reduced fluid volume or kidney function issues should use this medication with caution. This medication can lower blood pressure or decrease blood volume, so older patients or those on diuretics should carefully monitor their fluid status and kidney function. The blood sugar control effect of this medication may diminish in patients with moderate to severe kidney impairment, increasing the risk of serious side effects. When taking this medication, patients should watch for symptoms of side effects such as genital infections, urinary tract infections, hypoglycemia, reduced fluid volume, and diabetic ketoacidosis. Genital infections are more common in women, and patients with a history of infections are at higher risk of recurrence. Hypoglycemia can occur more frequently when used in combination with insulin or sulfonylurea, so caution should be exercised for signs of hypoglycemia and insulin dosage may need adjustment if taken together. If symptoms of reduced fluid volume or hypotension appear, immediate consultation with healthcare professionals is advised, and temporary cessation of medication may be necessary. Diabetic ketoacidosis can occur even when blood sugar levels are not high, so if symptoms such as vomiting, abdominal pain, or difficulty breathing appear, immediate examination is required. Patients with poor liver function or elderly patients should be particularly cautious when taking this medication, and regular checks of liver and kidney functions are advisable. Women who are pregnant or breastfeeding should not take this medication, and if pregnancy is confirmed, discontinuation should be immediate. The safety and efficacy of this medication in children have not been established, thus it should not be used. In cases of overdose, no specific antidote exists; therefore, it is important to receive appropriate treatment based on symptoms. This drug does not significantly affect the ability to drive or operate machinery, but caution should be exercised due to the risk of hypoglycemia. Lastly, this medication should be stored out of the reach of children and kept in its original container.

Side effects

vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal gangrene, hypoglycemia, decreased fluid volume, polydipsia, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, elevated hematocrit, decreased renal creatinine clearance at the beginning of treatment, dyslipidemia, elevated serum creatinine at the beginning of treatment, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, bile duct stones, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, chest pain, paresthesia, headache, dyspepsia, nausea, diarrhea, vomiting, urinary retention, elevated alanine aminotransferase, elevated aspartate aminotransferase, decreased appetite, dysgeusia, nasopharyngitis, upper respiratory infection, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, flu-like symptoms, vaginal discharge, menstrual irregularities, pruritus, urticaria, cold sweats, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture; therefore, it must be stored in a tightly sealed container. It is recommended to keep the storage temperature between 1 to 30 degrees Celsius at room temperature. This will help maintain the drug's efficacy over time.

Appearance and packaging

Appearance

Yellow, biconvex, diamond-shaped film-coated tablets

Package unit

PTP - 28 tablets/box [28 tablets (7 tablets/PTP x 4)], bottle - 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.